Lixte Biotechnology Holdings, Inc. (LIXT) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Lixte Biotechnology Holdings, Inc. (LIXT) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $79.5M, listed on NASDAQ, employing roughly 2 people, carrying a beta of 1.05 to the broader market. Lixte Biotechnology Holdings, Inc. Led by Geordan G. Pursglove, public since 2007-10-25.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for LIXT as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →